Bolt Biotherapeutics, Inc. (BOLT)
6.08
+0.17
(+2.88%)
USD |
NASDAQ |
Nov 13, 16:00
6.20
+0.12
(+1.97%)
Pre-Market: 19:59
Bolt Biotherapeutics Price : 6.08 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 6.03 | 6.20 | 5.915 | 6.08 | 28118.00 |
| Nov 12, 2026 | 6.19 | 6.355 | 5.87 | 5.91 | 177673.0 |
| Nov 11, 2026 | 6.38 | 6.38 | 6.18 | 6.26 | 42677.00 |
| Nov 10, 2026 | 6.160 | 6.66 | 6.160 | 6.30 | 111898.0 |
| Nov 09, 2026 | 6.56 | 6.57 | 6.100 | 6.43 | 98745.00 |
| Nov 06, 2026 | 6.37 | 6.55 | 6.29 | 6.54 | 136537.0 |
| Nov 05, 2026 | 6.39 | 6.525 | 6.13 | 6.38 | 170368.0 |
| Nov 04, 2026 | 6.53 | 6.54 | 6.16 | 6.54 | 85770.00 |
| Nov 03, 2026 | 6.32 | 6.74 | 6.10 | 6.57 | 51390.00 |
| Nov 02, 2026 | 6.58 | 6.58 | 6.18 | 6.24 | 50401.00 |
| Oct 30, 2026 | 6.28 | 6.59 | 6.09 | 6.59 | 249911.0 |
| Oct 29, 2026 | 6.47 | 6.61 | 6.30 | 6.36 | 76269.00 |
| Oct 28, 2026 | 6.34 | 6.60 | 6.28 | 6.58 | 82982.00 |
| Oct 27, 2026 | 6.58 | 6.64 | 6.22 | 6.37 | 177798.0 |
| Oct 26, 2026 | 6.66 | 6.865 | 6.200 | 6.59 | 423696.0 |
| Oct 23, 2026 | 6.98 | 7.78 | 5.99 | 6.27 | 12.88M |
| Oct 22, 2026 | 4.06 | 4.210 | 4.026 | 4.19 | 14054.00 |
| Oct 21, 2026 | 4.33 | 4.480 | 4.05 | 4.14 | 34466.00 |
| Oct 20, 2026 | 4.05 | 4.33 | 4.05 | 4.31 | 29274.00 |
| Oct 19, 2026 | 3.947 | 4.20 | 3.947 | 4.04 | 21942.00 |
| Oct 16, 2026 | 4.46 | 4.48 | 3.955 | 4.00 | 10118.00 |
| Oct 15, 2026 | 4.14 | 4.44 | 3.85 | 4.24 | 9255.00 |
| Oct 14, 2026 | 4.28 | 4.375 | 3.76 | 3.98 | 31071.00 |
| Oct 13, 2026 | 4.26 | 4.385 | 4.25 | 4.285 | 12826.00 |
| Oct 12, 2026 | 4.13 | 4.678 | 4.13 | 4.24 | 28728.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Caribou Biosciences, Inc. | 0.3619 |
| Oncolytics Biotech, Inc. | 0.37 |
| Sangamo Therapeutics, Inc. | 0.117 |
| Sarepta Therapeutics, Inc. | 16.07 |
| Anixa Biosciences, Inc. | 2.62 |
Price Related Metrics
| PS Ratio | 4.242 |
| Price to Book Value | 1.530 |
| Earnings Yield | -246.1% |
| Market Cap | 11.71M |